SafeBeat Rx
PrivateLast Round
Grant
Sep 17, 2024
Est. Valuation
$1.79M
Total Funding Raised
$2.71M
Company Overview
SafeBeat Rx is a healthtech company that develops artificial intelligence-based software for remote cardiac patient monitoring and therapeutic guidance.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, Health IoT, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeBeat Rx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
SafeBeat Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 17, 2024 | ||||
| Grant | Aug 5, 2024 | ||||
| Accelerator | Oct 9, 2022 | ||||
| Angel | Jul 3, 2022 | ||||
| Accelerator | Jun 7, 2022 | ||||
Seed | Sep 1, 2021 |
Key People
Founding team and executive leadership
SafeBeat Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zillionize | Seed |
| Fusion Fund | Seed |
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| Y Combinator | Seed |
| HealthTech Arkansas | Accelerator |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Grew 16% QoQ from 38 to 44 employees.
SafeBeat Rx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SafeBeat Rx's valuation, stock price, and market status.